These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010. Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216 [TBL] [Abstract][Full Text] [Related]
5. Association of Delays in Surgery for Melanoma With Insurance Type. Adamson AS; Zhou L; Baggett CD; Thomas NE; Meyer AM JAMA Dermatol; 2017 Nov; 153(11):1106-1113. PubMed ID: 28979974 [TBL] [Abstract][Full Text] [Related]
9. Delay of Surgery for Melanoma Among Medicare Beneficiaries. Lott JP; Narayan D; Soulos PR; Aminawung J; Gross CP JAMA Dermatol; 2015 Jul; 151(7):731-41. PubMed ID: 25853865 [TBL] [Abstract][Full Text] [Related]
10. Skin biopsy rates and incidence of melanoma: population based ecological study. Welch HG; Woloshin S; Schwartz LM BMJ; 2005 Sep; 331(7515):481. PubMed ID: 16081427 [TBL] [Abstract][Full Text] [Related]
11. Early detection of thick melanomas in the United States: beware of the nodular subtype. Demierre MF; Chung C; Miller DR; Geller AC Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921 [TBL] [Abstract][Full Text] [Related]
12. Skin biopsy utilization and melanoma incidence among Medicare beneficiaries. Weinstock MA; Lott JP; Wang Q; Titus LJ; Onega T; Nelson HD; Pearson L; Piepkorn M; Barnhill RL; Elmore JG; Tosteson ANA Br J Dermatol; 2017 Apr; 176(4):949-954. PubMed ID: 27639256 [TBL] [Abstract][Full Text] [Related]
13. The increasing use of shave biopsy for diagnosing invasive melanoma in Australia. de Menezes SL; Kelly JW; Wolfe R; Farrugia H; Mar VJ Med J Aust; 2019 Sep; 211(5):213-218. PubMed ID: 31328802 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors. Lezcano C; Jungbluth AA; Busam KJ Am J Surg Pathol; 2020 Jul; 44(7):893-900. PubMed ID: 32317605 [TBL] [Abstract][Full Text] [Related]
16. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study. Thomas NE; Kricker A; Waxweiler WT; Dillon PM; Busman KJ; From L; Groben PA; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Orlow I; Paine S; Ollila DW; Reiner AS; Luo L; Hao H; Frank JS; Begg CB; Berwick M; JAMA Dermatol; 2014 Dec; 150(12):1306-314. PubMed ID: 25162299 [TBL] [Abstract][Full Text] [Related]
17. Five-Year Outcomes of a Melanoma Screening Initiative in a Large Health Care System. Matsumoto M; Wack S; Weinstock MA; Geller A; Wang H; Solano FX; Kirkwood JM; Ferris LK JAMA Dermatol; 2022 May; 158(5):504-512. PubMed ID: 35385051 [TBL] [Abstract][Full Text] [Related]
18. Assessment of a Diagnostic Classification System for Management of Lesions to Exclude Melanoma. Katz I; O'Brien B; Clark S; Thompson CT; Schapiro B; Azzi A; Lilleyman A; Boyle T; Espartero LJL; Yamada M; Prow TW JAMA Netw Open; 2021 Dec; 4(12):e2134614. PubMed ID: 34889949 [TBL] [Abstract][Full Text] [Related]
19. Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist. Pennie ML; Soon SL; Risser JB; Veledar E; Culler SD; Chen SC Arch Dermatol; 2007 Apr; 143(4):488-94. PubMed ID: 17438181 [TBL] [Abstract][Full Text] [Related]
20. Association Between Health Maintenance Practices and Skin Cancer Risk as a Possible Source of Detection Bias. Drucker AM; Li WQ; Savitz DA; Weinstock MA; Han J; Li T; Qureshi AA; Cho E JAMA Dermatol; 2019 Mar; 155(3):353-357. PubMed ID: 30586131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]